The University of Chicago Header Logo

Connection

Hedy Kindler to Fanconi Anemia Complementation Group N Protein

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Fanconi Anemia Complementation Group N Protein.
Hedy Kindler
Connection Strength
0.184
Fanconi Anemia Complementation Group N Protein
  1. Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation. J Clin Oncol. 2020 05 01; 38(13):1378-1388.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.